RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Viking Global Investors
V

Viking Global Investors portfolio

Viking Global Investors has 19 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 19.
Deals, last 12 months: 3.
Rounds led: 11 of 26.
Capital in their rounds: $3.03B.
Latest deal: TriGemX Bio · Oct 1, 2026.
About this page

It led 11 of the 26 rounds it joined. Its most recent investment on record is TriGemX Bio's $94M funding round in October 2026, alongside TCG Crossover and The Column Group. By category, its portfolio leans toward Health and bio (13) and Data and analytics (4). It has co-invested with GV, Goldman Sachs Asset Management and Andreessen Horowitz, most often GV (6 rounds).

What Viking Global Investors invests in

Viking Global Investors recent investments

How Viking Global Investors invests

StageDealsCapital in rounds
Series B+ 24 92%$2.86B
round 1 4%$94M
Series A 1 4%$75M
YearDealsCapital in rounds
2015 1 4%$108M
2017 1 4%$75M
2018 1 4%$70M
2019 1 4%$300M
2020 2 8%$332M
2021 5 19%$733M
2022 2 8%$123M
2023 5 19%$634M
2024 3 12%$170M
2025 2 8%$181M
2026 3 12%$303.5M

Viking Global Investors portfolio companies

CompanyRound with Viking Global InvestorsTotal raisedLatest raise
TTriGemX Bio
Health and bio
round · $94M$94MOct 1, 2026
round
PPearl Health
Health and bio
Series B+ · $110M$203MJul 8, 2026
Series B+
CCity Therapeutics
Health and bio
Series B+ · $99.5M · lead$234.5MAug 8, 2026
Series B+
SStar Therapeutics
Health and bio
Series B+ · $125M · lead$415MOct 23, 2026
Series B+
AAntheia
Legal and compliance
Series B+ · $56M$153MJan 27, 2026
Series B+
AAlphaSense
Data and analytics
Series B+ · lead$830MJun 3, 2026
round
AAreteia Therapeutics
Health and bio
Series A · $75M$75MFeb 13, 2024
Series A
HHI-Bio
Health and bio
Series B+ · $95M$215MJan 4, 2024
Series B+
LLightmatter
AI infrastructure and compute
Series B+ · $155M · lead$800MOct 21, 2024
Series B+
LLocus Biosciences
Health and bio
Series B+ · $35M$54MFeb 16, 2024
Series B+
CCognism
Sales and marketing
Series B+ · $88M · lead$116.91MJan 13, 2022
Series B+
CCloudbeds
Sales and marketing
Series B+ · $150M$244MNov 3, 2021
Series B+
AApeel Sciences
Commerce and retail
Series B+ · $250M$603MOct 22, 2025
Series B+
IImpossible Foods
Commerce and retail
Series B+ · $300M$1.68BNov 23, 2021
Series B+
CCreditKarma
Stablecoins
backerundisclosed—
EEnsoma
Health and bio
backer$50MMay 16, 2023
Series B+
AAsset Watch
Data and analytics
backerundisclosedMar 2, 2026
Series B+
BBiomEdit
Health and bio
backerundisclosedFeb 16, 2026
Series B+
VVelosbio
Health and bio
backer$58MAug 2, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 26 rounds on Recent Funding that name Viking Global Investors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Viking Global Investors, which is a subset of its real portfolio. API: /api/v1/investors/viking-global-investors (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy